BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 20802484)

  • 21. The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen.
    Kawamoto S; Yalcindag A; Laouini D; Brodeur S; Bryce P; Lu B; Humbles AA; Oettgen H; Gerard C; Geha RS
    J Clin Invest; 2004 Aug; 114(3):399-407. PubMed ID: 15286806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C3a is required for ILC2 function in allergic airway inflammation.
    Gour N; Smole U; Yong HM; Lewkowich IP; Yao N; Singh A; Gabrielson E; Wills-Karp M; Lajoie S
    Mucosal Immunol; 2018 Nov; 11(6):1653-1662. PubMed ID: 30104625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative regulation of pulmonary Th17 responses by C3a anaphylatoxin during allergic inflammation in mice.
    Lim H; Kim YU; Drouin SM; Mueller-Ortiz S; Yun K; Morschl E; Wetsel RA; Chung Y
    PLoS One; 2012; 7(12):e52666. PubMed ID: 23285141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined administration of anti-IL-13 and anti-IL-17A at individually sub-therapeutic doses limits asthma-like symptoms in a mouse model of Th2/Th17 high asthma.
    Kim D; McAlees JW; Bischoff LJ; Kaur D; Houshel LK; Gray J; Hargis J; Davis X; Dudas PL; Deshmukh H; Lewkowich IP
    Clin Exp Allergy; 2019 Mar; 49(3):317-330. PubMed ID: 30353972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement mediators: key regulators of airway tissue remodeling in asthma.
    Khan MA; Assiri AM; Broering DC
    J Transl Med; 2015 Aug; 13():272. PubMed ID: 26289385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement C3a-induced IL-17 plays a critical role in an IgE-mediated late-phase asthmatic response and airway hyperresponsiveness via neutrophilic inflammation in mice.
    Mizutani N; Goshima H; Nabe T; Yoshino S
    J Immunol; 2012 Jun; 188(11):5694-705. PubMed ID: 22539791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
    Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
    J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
    Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
    J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Mechanisms of Airway Hyperresponsiveness in a Murine Model of Steroid-Resistant Airway Inflammation.
    Manni ML; Mandalapu S; McHugh KJ; Elloso MM; Dudas PL; Alcorn JF
    J Immunol; 2016 Feb; 196(3):963-77. PubMed ID: 26729801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma.
    Krug N; Tschernig T; Erpenbeck VJ; Hohlfeld JM; Köhl J
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1841-3. PubMed ID: 11734433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells.
    Shivshankar P; Li YD; Mueller-Ortiz SL; Wetsel RA
    FASEB J; 2020 Jun; 34(6):7540-7560. PubMed ID: 32301538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralization of either IL-17A or IL-17F is sufficient to inhibit house dust mite induced allergic asthma in mice.
    Chenuet P; Fauconnier L; Madouri F; Marchiol T; Rouxel N; Ledru A; Mauny P; Lory R; Uttenhove C; van Snick J; Iwakura Y; di Padova F; Quesniaux V; Togbe D; Ryffel B
    Clin Sci (Lond); 2017 Oct; 131(20):2533-2548. PubMed ID: 29026003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of IL-4 receptor alpha on smooth muscle cells is not necessary for development of experimental allergic asthma.
    Kirstein F; Horsnell WG; Kuperman DA; Huang X; Erle DJ; Lopata AL; Brombacher F
    J Allergy Clin Immunol; 2010 Aug; 126(2):347-54. PubMed ID: 20579713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma.
    Karp CL; Grupe A; Schadt E; Ewart SL; Keane-Moore M; Cuomo PJ; Köhl J; Wahl L; Kuperman D; Germer S; Aud D; Peltz G; Wills-Karp M
    Nat Immunol; 2000 Sep; 1(3):221-6. PubMed ID: 10973279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
    Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
    J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct effects of endogenous interleukin-23 on eosinophilic airway inflammation in response to different antigens.
    Ogawa R; Suzuki Y; Kagawa S; Masaki K; Fukunaga K; Yoshimura A; Fujishima S; Terashima T; Betsuyaku T; Asano K
    Allergol Int; 2015 Sep; 64 Suppl():S24-9. PubMed ID: 26344076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR9-IL-2 axis exacerbates allergic asthma by preventing IL-17A hyperproduction.
    Murakami Y; Ishii T; Nunokawa H; Kurata K; Narita T; Yamashita N
    Sci Rep; 2020 Oct; 10(1):18110. PubMed ID: 33093516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A role for the C3a anaphylatoxin receptor in the effector phase of asthma.
    Humbles AA; Lu B; Nilsson CA; Lilly C; Israel E; Fujiwara Y; Gerard NP; Gerard C
    Nature; 2000 Aug; 406(6799):998-1001. PubMed ID: 10984054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-Glucan exacerbates allergic asthma independent of fungal sensitization and promotes steroid-resistant T
    Zhang Z; Biagini Myers JM; Brandt EB; Ryan PH; Lindsey M; Mintz-Cole RA; Reponen T; Vesper SJ; Forde F; Ruff B; Bass SA; LeMasters GK; Bernstein DI; Lockey J; Budelsky AL; Khurana Hershey GK
    J Allergy Clin Immunol; 2017 Jan; 139(1):54-65.e8. PubMed ID: 27221135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of complement in the diagnosis and management of allergic rhinitis and allergic asthma.
    Laumonnier Y; Schmudde I; Köhl J
    Curr Allergy Asthma Rep; 2011 Apr; 11(2):122-30. PubMed ID: 21170614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.